BioRestorative Therapies, Inc. (BRTX) vs FibroBiologics, Inc. Common Stock (FBLG)
A side-by-side comparison of BioRestorative Therapies, Inc. and FibroBiologics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BRTX
BioRestorative Therapies, Inc.
$2.30HealthcareDelayed quote: Oct 6, 2026, 10:06 AM EDT
FBLG
FibroBiologics, Inc. Common Stock
$1.16HealthcareDelayed quote: Oct 6, 2026, 10:00 AM EDT
Total return — BRTX vs FBLG
growth of $100 · dividends reinvested · last 3yBRTX -92.8% (-58.4%/yr)FBLG -99.8% (-87.3%/yr)BRTX compounded faster over this window
Log scale — wide-divergence pair
BRTX FBLG
BRTX vs FBLG: by the numbers
- •BRTX is the larger company ($3M vs $2M market cap).
- •Both run net losses; FBLG's is the smaller (0.00% vs -3089.55% net margin).
Metrics side by side
Valuation
| Metric | BRTX | FBLG |
|---|---|---|
| P/S ratio | 8.88 | N/A |
| P/B ratio | 1.05 | 0.52 |
Profitability
| Metric | BRTX | FBLG |
|---|---|---|
| Gross margin | 92.09% | 0.00% |
| Operating margin | -4350.05% | 0.00% |
| Net margin | -3089.55% | 0.00% |
| ROE | -365.43% | -391.26% |
| ROIC | -464.86% | -286.46% |
Growth (annualized)
| Metric | BRTX | FBLG |
|---|---|---|
| Revenue CAGR (5Y) | 38.99% | N/A |
| Total return CAGR (5Y) | -61.44% | N/A |
Go deeper
Dig into the metrics
BioRestorative Therapies ROEFibroBiologics, Inc. Common Stock ROEBioRestorative Therapies operating marginFibroBiologics, Inc. Common Stock operating marginBioRestorative Therapies revenue growthFibroBiologics, Inc. Common Stock revenue growthBioRestorative Therapies free cash flowFibroBiologics, Inc. Common Stock free cash flow
BioRestorative Therapies & FibroBiologics, Inc. Common Stock appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.